Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-344682

CEO acquired 4,363 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Weis Holger CEO 2026-08-06 Grant or award +4,363 $2.01 $8,770 25,483 D
Loading xslF345X06/ownership.xml…